Dr. Reddy's Laboratories saw its stock fall 0.44% to trade around Rs 1,382.00 by mid-morning on November 18, 2026, after touching a low of Rs 1,381.4. The company currently commands a market capitalization of 115,235.96 with a price-to-earnings ratio standing at 41.22. Despite this dip, the pharmaceutical company maintains a low six-month beta of 0.2055, reflecting strong market stability alongside a solid 12.57% return delivered over the trailing month.
Key points
A six-month beta of 0.2055 indicates that the pharmaceutical stock maintains a relatively…: A six-month beta of 0.2055 indicates that the pharmaceutical stock maintains a relatively steady presence in the financial markets.
Longer-term trends remain favorable for the drugmaker following a 12.57% gain over the pa…: Longer-term trends remain favorable for the drugmaker following a 12.57% gain over the past month.
The company's sustained performance is highlighted by an overall five-year market return…: The company's sustained performance is highlighted by an overall five-year market return of 48.01%.
Sources checked by our analysis pipeline: 1
18 Nov 2026 | 10:47:57 AM IST
Dr Reddys share price live updates
Join us on the Dr Reddys Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock. Stay in the know with the latest information about Dr Reddys, including: Last traded price 1381.4, Market capitalization: 115235.96, Volume: 185121, Price-to-earnings ratio 41.22, Earnings per share 33.54. Our liveblog provides a well-rounded view of Dr Reddys by incorporating both fundamental and technical indicators. Be the first to receive breaking news that can impact Dr Reddys's performance in the market. Our expert analysis and recommendations empower you to make informed investment choices. Stay informed and stay ahead with the Dr Reddys Stock Liveblog. The data points are updated as on 10:47:56 AM IST, 18 Nov 2026
Show more Show less
1 New Update
10:47:49 AM IST, 18 Nov 2026
Dr Reddys Share Price Live Updates: Dr. Reddys Stock Update
Dr. Reddys is currently trading at Rs 1382.00, showing a decline of 0.44% today, with a trading volume of 185,015 shares.
The pharmaceutical firm's recent market momentum is anchored by a sharp quarterly turnaround, swinging from a net loss to solid profitability alongside revenue growth. Heavy trading volumes have propelled the equity above critical moving averages despite broader market weakness. This operational recovery has positioned the asset near major multi-month resistance boundaries.
The Italian subsidiary has outlined a strategic shift to bolster profitability across its operations over the coming years. By establishing an aggressive multi-year performance objective, leadership is signaling a renewed focus on core commercial execution and capital efficiency. Meeting these profitability goals will be critical for the parent banking group's broader European expansion roadmap.